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Carbapenem-resistant Enterobacteriaceae (CRE) are a growing threat to infectious disease treatment and control (1) . Rapid detection of CRE, particularly carbapenemase-producing CRE (CP-CRE), and typing of carbapenemases are important for preventing and controlling outbreaks of CRE (2) . GeneXpert  systems have recently been developed for the automated detection of target genes. Integrated with the Xpert  Carba-R assay, GeneXpert  systems can detect 5 types of carbapenemase genes (bla IMP-1 , bla KPC , bla VIM , bla OXA-48 , and bla NDM ) from rectal swabs or isolates in 2 easy steps that can be completed within 1 h (3). However, few studies to verify the accuracy of the Xpert  Carba-R assay have been conducted in North America and Europe (3) (4) (5) , and no such studies have been conducted in Japan, where the epidemiology of CRE is far different from that in Western countries (6) . First, IMP-type carbapenemases are most prevalent in Japan. Although the manufacturer reported high sensitivity of the Xpert  Carba-R assay for bla IMP-1 detection (3), few other studies have confirmed this result. However, several studies have evaluated the sensitivity of the Xpert  Carba-R assay for the detection of other types of carbapenemases. Second, Enterobacter species are the most common CRE in Japan (7) , while Klebsiella species are dominant in Western countries (1) . Although the manufacturer evaluated the sensitivity of the Xpert  Carba-R assay using Enterobacter strains, the number of tested strains was small (3). The most important challenge for Japanese clinicians is the ability to accurately identify CP-CRE among a large number of carbapenem-resistant Enterobacter isolates. Therefore, the clinical utility of the Xpert  Carba-R assay in Japan remains unclear. Thus, the aim of this study was to evaluate the clinical utility of the Xpert  Carba-R assay using CRE isolated in a university hospital in Japan.
This study included all CRE isolates collected in Keio University Hospital between January 2014 and December 2014. Duplicate isolates collected from the same patient were excluded. We used the following criteria to define CRE, in accordance with the Infectious Diseases Control Law in Japan: minimum inhibitory concentration (MIC) of meropenem was no less than 2 mg/mL, or MIC of imipenem was no less than 2 mg/mL and that of cefmetazole was no less than 64 mg/mL. During the study period, 43 CRE isolates met the inclusion criteria, including 29 Enterobacter isolates, 10 Klebsiella pneumoniae isolates, 2 Escherichia coli isolates, 1 Citrobacter freundii complex isolate, and 1 Serratia marcescens isolate. CRE isolates stored at -809 C were thawed and cultured on sheep blood agar plates (Nissui, Tokyo, Japan) for 20 h to obtain colonies. Each isolate was evaluated for the presence of carbapenemase genes using the Xpert  Carba-R assay cartridge, which was loaded into the GeneXpert  VI system according to the manufacturer's instructions (3) . We also evaluated the isolates for the presence of carbapenemase genes using a conventional PCR assay. DNA was extracted from each CRE isolate by the boiling method (1009 C, 10 min), adjusted to a concentration of 50 ng/mL, and used as template. Amplification was performed using previously described primer pairs for bla IMP-1 and bla VIM-2 (8) , bla NDM (9), bla KPC (10), and bla OXA-48 (11) . One microliter of each primer (10 mM) was added to 10 mL of PCR master mix (Ampdirect  , Shimadzu, Kyoto, Japan), 0.1 mL of BioTaq TM HS DNA polymerase (Shimadzu), 6.9 mL of H 2 O, and 1 mL of DNA template. The thermocycling conditions were as follows: 1 cycle at 959 C for 10 min, followed by 30 cycles at 949 C for 15 s, 559 C for 30 s, and 729 C for 60 s, and a final cycle at 729 C for 7 min. The PCR products were electrophoresed using the MCE  -202 MultiNA Microchip Electrophoresis System (Shimadzu).
We calculated the sensitivity and specificity of the Xpert  Carba-R assay for the detection of bla IMP-1 , bla KPC , bla OXA-48 , bla NDM , and bla VIM-2 . The PCR results were used as the reference for the Xpert  Carba-R assay. The study protocol was approved by the Ethics Committee of Keio University School of Medicine.
The results of the Xpert  Carba-R assay and the PCR assay are shown in Table 1 . No isolates harbored bla NDM , bla KPC , bla OXA-48 , or bla VIM-2 . PCR analysis identified 14 isolates as positive for bla IMP-1 . The Xpert  Carba-R assay identified 13 of these isolates as positive and 1 as negative for bla IMP-1 . Thus, the sensitivity and specificity of the Xpert  Carba-R assay for detecting the 5 carbapenemase genes were 92.9z and 100z, respectively, in reference to the conventional PCR assay. The only carbapenemase gene detected in this study was bla IMP-1 . This result is consistent with the findings of a previous epidemiological study of carbapenemases in Japan (7) . In Japan, IMP-type carbapenemases are the most prevalent, whereas OXA-48, NDM, and KPC carbapenemases are extremely rare.
Our results indicate that the Xpert  Carba-R assay has high sensitivity and specificity for the detection of carbapenemase genes in CRE. To the best of our knowledge, only 4 previous studies have tested the accuracy of carbapenemase gene detection using the Xpert  system (3) (4) (5) 12) , and strains positive for bla IMP-1 were included in only 2 of those studies. In a multisite prospective study performed by Cepheid Inc. (3), 27 isolates positive for bla IMP-1 were collected from 3 reference laboratories in the United States and Europe. The sensitivity and specificity of the Xpert  Carba-R assay for bla IMP-1 detection were 96.3z and 100z, respectively. In the other study (4) , performed in England, the sensitivity of the assay for bla IMP detection was very low (71z). The sensitivity in the present study was much higher than that in the latter study.
In the present study, an S. marcescens isolate was identified as positive for bla IMP-1 by the conventional PCR assay but not by the Xpert  Carba-R assay. Although the exact cause of this discrepancy is unknown, there are several possibilities. The first possibility is manipulation error; however, the isolate was tested twice using the Xpert  Carba-R assay and 3 times using conventional PCR, so this possibility is unlikely. The second possibility is that the primers for bla IMP-1 used in the Xpert  Carba-R assay and those used for conventional PCR in this study amplify variant IMP-1 carbapenemase genes (8) . The final possibility is suboptimal performance of the Xpert  Carba-R assay. Since the complete process of carbapenemase gene detection has not been disclosed by the manufacturer, the efficacy of DNA extraction and amplification is not clear. Despite the discrepancy, we conclude that the Xpert  Carba-R assay may be useful in regions where carbapenem-resistant Enterobacter strains producing IMP-type carbapenemases are most prevalent, such as in Japan.
